🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are trying to determine the side effects on the heart from immu...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2020-08-14
Trial ID
NCT04538950
Treatments Being Tested
This phase I trial studies the side effects and how well light dosimetry sy...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2021-09-17
Trial ID
NCT03678350
Treatments Being Tested
This is a multi-center, prospective clinical study designed to evaluate the...
Status
Recruiting
Location
ZhuHai Hospital
Start Date
2024-12-01
Trial ID
NCT06755060
Treatments Being Tested
The purpose of this study is to characterize the safety and tolerability an...
Status
Completed
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02476123
Treatments Being Tested
The purpose of this study is to explore the influence of neoadjuvant chemot...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-04-17
Trial ID
NCT04408859
Treatments Being Tested
The primary purpose is to determine the changes in gene expression induced ...
Status
Completed
Location
University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital
Start Date
2004-10
Trial ID
NCT00137176
Treatments Being Tested
The objective of this retrospective study is to determine the survival rate...
Status
Unknown
Location
Rigshospitalet
Start Date
2024-02-01
Trial ID
NCT06369480
This study is conducted to investigate whether modified chemoradiotherapy w...
Status
Recruiting
Location
National Cancer Center Hospital
Start Date
2020-07-01
Trial ID
NCT04328948
Treatments Being Tested
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2002-05
Trial ID
NCT00042835
The main purpose of this study is to find out the most suitable dose (recom...
Status
Recruiting
Location
New York University Langone Medical Center
Start Date
2026-03-03
Trial ID
NCT07227025
Treatments Being Tested